| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8766739 | Progrès en Urologie | 2017 | 22 Pages |
Abstract
The post-treatment pathological evaluation by biopsies (targeted with MRI or, perhaps in a near future, with innovative ultrasonography) is the corner stone of oncological evaluation of ablative therapies. Ongoing trials will allow to standardize the follow-up and determine the best indication and the best techniques in order to optimize oncological and functional results for each patient treated.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
R. Renard-Penna, R. Sanchez-Salas, E. Barret, J.M. Cosset, S. de Vergie, J. Sapetti, A. Ingels, A. Gangi, H. Lang, X. Cathelineau,